Literature DB >> 18194305

Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding.

M Economou, A Teli, A Tzantzaroudi, I Tsatra, A Zavitsanakis, M Athanassiou-Metaxa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18194305     DOI： 10.1111/j.1365-2516.2007.01635.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  3 in total

1.  7 Procoagulators.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

Review 2.  Emerging and future therapies for hemophilia.

Authors:  Marcus E Carr; Bartholomew J Tortella
Journal:  J Blood Med       Date:  2015-09-03

3.  [Perioperative application of recombinant human coagulation factor Ⅶa combined with prothrombin complex in two hemophilia A patients with high titer inhibitor].

Authors:  P P Xu; H Zhou; P Zhang; J Q Wang; L Liu; C Li; M J Li; G P Li; B J Ding; J P Liu; X R Wang; Y P Song
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-09-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.